RHHBY
Price
$45.52
Change
+$0.09 (+0.20%)
Updated
Nov 13 closing price
Capitalization
290.95B
76 days until earnings call
Intraday BUY SELL Signals
RHHVF
Price
$364.16
Change
+$2.16 (+0.60%)
Updated
Nov 13 closing price
Capitalization
290.95B
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RHHBY vs RHHVF

Header iconRHHBY vs RHHVF Comparison
Open Charts RHHBY vs RHHVFBanner chart's image
Roche Holding
Price$45.52
Change+$0.09 (+0.20%)
Volume$1.86M
Capitalization290.95B
Roche Holding
Price$364.16
Change+$2.16 (+0.60%)
Volume$396
Capitalization290.95B
RHHBY vs RHHVF Comparison Chart in %
RHHBY
Daily Signal:
Gain/Loss:
RHHVF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RHHBY vs. RHHVF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBY is a StrongBuy and RHHVF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (RHHBY: $45.52 vs. RHHVF: $364.16)
Brand notoriety: RHHBY and RHHVF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBY: 124% vs. RHHVF: 5%
Market capitalization -- RHHBY: $290.95B vs. RHHVF: $290.95B
RHHBY [@Pharmaceuticals: Major] is valued at $290.95B. RHHVF’s [@Pharmaceuticals: Major] market capitalization is $290.95B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $915.49B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $98.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBY’s FA Score shows that 2 FA rating(s) are green whileRHHVF’s FA Score has 2 green FA rating(s).

  • RHHBY’s FA Score: 2 green, 3 red.
  • RHHVF’s FA Score: 2 green, 3 red.
According to our system of comparison, both RHHBY and RHHVF are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBY’s TA Score shows that 4 TA indicator(s) are bullish while RHHVF’s TA Score has 4 bullish TA indicator(s).

  • RHHBY’s TA Score: 4 bullish, 6 bearish.
  • RHHVF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than RHHVF.

Price Growth

RHHBY (@Pharmaceuticals: Major) experienced а +10.43% price change this week, while RHHVF (@Pharmaceuticals: Major) price change was +11.60% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +4.18%. For the same industry, the average monthly price growth was +2.11%, and the average quarterly price growth was +20.10%.

Reported Earning Dates

RHHBY is expected to report earnings on Jan 29, 2026.

RHHVF is expected to report earnings on Jan 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+4.18% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($291B) and RHHVF($291B) have the same market capitalization . RHHBY (24.83) and RHHVF (24.83) have similar P/E ratio . RHHBY YTD gains are higher at: 34.578 vs. RHHVF (29.286). RHHBY (18B) and RHHVF (18B) have comparable annual earnings (EBITDA) . RHHBY (12B) and RHHVF (12B) have equal amount of cash in the bank . RHHBY (33B) and RHHVF (33B) have identical debt. RHHBY (63.5B) and RHHVF (63.5B) have equivalent revenues.
RHHBYRHHVFRHHBY / RHHVF
Capitalization291B291B100%
EBITDA18B18B100%
Gain YTD34.57829.286118%
P/E Ratio24.8324.83100%
Revenue63.5B63.5B100%
Total Cash12B12B100%
Total Debt33B33B100%
FUNDAMENTALS RATINGS
RHHBY vs RHHVF: Fundamental Ratings
RHHBY
RHHVF
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
6890
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4647
P/E GROWTH RATING
1..100
2121
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (14) in the null industry is in the same range as RHHVF (14). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's Profit vs Risk Rating (68) in the null industry is in the same range as RHHVF (90). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's SMR Rating (98) in the null industry is in the same range as RHHVF (98). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's Price Growth Rating (46) in the null industry is in the same range as RHHVF (47). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's P/E Growth Rating (21) in the null industry is in the same range as RHHVF (21). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBYRHHVF
RSI
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
61%
Momentum
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
63%
MACD
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
54%
Advances
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 3 days ago
54%
Declines
ODDS (%)
Bearish Trend 18 days ago
45%
Bearish Trend 18 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
57%
Aroon
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBY
Daily Signal:
Gain/Loss:
RHHVF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNPX4.600.55
+13.58%
Genprex Inc.
MKC65.880.17
+0.26%
McCormick & Company
AKR20.170.01
+0.05%
Acadia Realty Trust
WHWK2.23N/A
N/A
Whitehawk Therapeutics Inc
ADSE10.18-0.02
-0.20%
Ads-Tec Energy PLC

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
N/A
RHHVF - RHHBY
65%
Loosely correlated
+1.08%
NVS - RHHBY
37%
Loosely correlated
+1.37%
JNJ - RHHBY
37%
Loosely correlated
+0.29%
RHHBF - RHHBY
32%
Poorly correlated
N/A
BMY - RHHBY
28%
Poorly correlated
+0.74%
More

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
+1.08%
RHHBY - RHHVF
65%
Loosely correlated
N/A
JNJ - RHHVF
31%
Poorly correlated
+0.29%
NVS - RHHVF
27%
Poorly correlated
+1.37%
AZN - RHHVF
26%
Poorly correlated
-1.58%
RHHBF - RHHVF
25%
Poorly correlated
N/A
More